Search
CapsoVision Inc
CVAdd to Watchlist
6.455USD
-0.845-11.58%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
322.51MMarket Cap
LossP/E TTM
More Details of CapsoVision Inc Company
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
CapsoVision Inc Info
Ticker SymbolCV
Company nameCapsoVision Inc
IPO dateJul 02, 2025
CEOWang (Kang-Huai)
Number of employees90
Security typeOrdinary Share
Fiscal year-endJul 02
Address18805 Cox Avenue
CitySARATOGA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95070
Phone14086241488
Websitehttps://www.capsovision.com/
Ticker SymbolCV
IPO dateJul 02, 2025
CEOWang (Kang-Huai)
Company Executives of CapsoVision Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
721.73K
-52.97%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.36K
-0.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
107.36K
--
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
23.60K
-87.77%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
13.24K
-78.20%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.78K
-3.92%
Dr. Joanne Imperial, M.D.
Dr. Joanne Imperial, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Min-Liang Chen
Mr. Min-Liang Chen
Director
Director
--
--
Mr. Eliyahou Harari
Mr. Eliyahou Harari
Director
Director
--
--
Mr. Howard Lee
Mr. Howard Lee
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
721.73K
-52.97%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.36K
-0.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
107.36K
--
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
23.60K
-87.77%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
13.24K
-78.20%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.78K
-3.92%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
By BusinessUSD
Name
Revenue
Proportion
Products (capsules and capsule reading devices)
12.64M
93.24%
Services (cloud-based video delivery and reading services)
916.00K
6.76%
By RegionUSD
Name
Revenue
Proportion
United States
10.66M
78.63%
Outside United States
2.90M
21.37%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Products (capsules and capsule reading devices)
12.64M
93.24%
Services (cloud-based video delivery and reading services)
916.00K
6.76%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Ching-Hang (Shen)
12.84%
Harari Eliyahou Et Al
10.23%
Kioxia Corporation
6.91%
Vanguard Capital Management, LLC
2.06%
Wang (Kang-Huai)
1.45%
Other
66.51%
Shareholders
Shareholders
Proportion
Ching-Hang (Shen)
12.84%
Harari Eliyahou Et Al
10.23%
Kioxia Corporation
6.91%
Vanguard Capital Management, LLC
2.06%
Wang (Kang-Huai)
1.45%
Other
66.51%
Shareholder Types
Shareholders
Proportion
Individual Investor
14.99%
Other Insider Investor
10.23%
Corporation
6.91%
Investment Advisor
3.47%
Investment Advisor/Hedge Fund
0.68%
Research Firm
0.05%
Hedge Fund
0.03%
Insurance Company
0.02%
Bank and Trust
0.02%
Other
63.59%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
37
408.58K
0.06%
--
2026Q1
65
2.27M
4.55%
+1.82M
2025Q4
39
481.38K
1.03%
+382.86K
2025Q3
11
196.14K
0.42%
+171.24K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Ching-Hang (Shen)
3.99M
8.01%
+81.00K
+2.07%
Oct 01, 2025
Harari Eliyahou Et Al
4.31M
8.64%
+4.31M
--
Jul 02, 2025
Kioxia Corporation
3.45M
6.92%
+3.45M
--
Jul 02, 2025
Wang (Kang-Huai)
1.10M
2.22%
+1.10M
--
Jul 03, 2025
BlackRock Institutional Trust Company, N.A.
228.77K
0.46%
+175.75K
+331.52%
Dec 31, 2025
Geode Capital Management, L.L.C.
154.26K
0.31%
+39.23K
+34.10%
Dec 31, 2025
Tsai (Chen Lung)
118.36K
0.24%
+2.89K
+2.50%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
